Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 17:105252.
doi: 10.1016/j.exphem.2025.105252. Online ahead of print.

A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCs

Pawan Bhat  1 , Joseph C Van Amburg  2 , Chad R Potts  3 , Thomas J Gracie  3 , Justin A Cartailler  3 , Alyssa C Parker  2 , Michael R Savona  3 , Rui Lu  4 , Stanley C Lee  5 , Robert S Welner  4 , Alexander G Bick  6 , P Brent Ferrell Jr  7
Affiliations
Free article

A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCs

Pawan Bhat et al. Exp Hematol. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure PBF is supported by a Mark Foundation for Cancer Research Endeavor Award, a Novartis Global Scholar Award, NIDDK R56 (R56DK138826), and a VA MERIT Award (I01BX005991). AGB is on the scientific advisory board of NashBio. RSW is supported by the Mark Foundation for Cancer Research Endeavor Award, the Edward P. Evans Foundation, and the O'Neal Comprehensive Cancer Center. RL is supported by the Mark Foundation for Cancer Research Endeavor Award, NIH/NCI (R01CA259480), American Cancer Society (RSG-22-036-01-DMC), and the Gabrielle’s Angel Foundation for Cancer Research. MRS reports consultancy or membership on a board or advisory committee for BMS, CTI, Forma, Geron, GSK, Karyopharm, Rigel, Ryvu, Taiho, and Treadwell; patents and royalties from Boehringer Ingelheim and Empath Biosciences; research funding from ALX Oncology, Astex, Incyte, Takeda, and TG Therapeutics; and equity in Empath Biosciences, Karyopharm, and Ryvu. The other authors do not have any conflicts of interest to declare in relation to this work.

LinkOut - more resources